Delivery Order SPE2DB20D2104-SPE2DB24FR11V
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,051.54 firm fixed-price delivery order is for 90 capsules of 40 mg Omeprazole DR (delayed-release omeprazole), a medication used to treat conditions such as acid reflux and ulcers. The contract has an ultimate completion date of May 10, 2023. This award is part of a larger $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,739.59 firm fixed-price delivery order is for 500 capsules of 40 mg Omeprazole Delayed-Release medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of omeprazole delayed-release 40 mg capsules in quantities of 1,000 for the Defense Logistics Agency (DLA). The one-year delivery order contract, valued at $1,188.12, is a firm fixed-price arrangement with a completion date of January 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,845,873 units of 40 mg omeprazole delayed-release capsules. The contract has a ceiling value of $2,288.34 and runs through April 9, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Omeprazole DR 40 mg capsule 90s, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,899.73, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,834.08 firm fixed-price delivery order covers the supply of 1,000 units of Omeprazole DR 20 mg capsules, a medication commonly used to treat gastric conditions. The contract has a completion date of January 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of 4,565,165,305 units of omeprazole DR 20 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,111.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 17, 2024 and is a firm fixed-price delivery order. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,596,812 units of omeprazole delayed-release capsules. The $1,188.12 Firm Fixed Price Delivery Order has a completion date of February 9, 2024 and does not have a set-aside designation. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds several Indefinite Delivery Contracts (IDCs) with DLA and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.80 firm fixed price delivery order is for the supply of 100 count capsules of 40 mg Omeprazole DR, a medication used for gastric conditions. The award has an ultimate completion date of October 31, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $1,080.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,855 units of omeprazole delayed-release 20 mg capsules. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR11VDelivery Order
This federal contract award is for the delivery of omeprazole delayed-release capsules, a medication used to treat conditions like acid reflux and stomach ulcers. The $1,784.64 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC with the DLA Troop Support Medical covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract award did not utilize any set-aside designations, indicating full and open competition. Amerisourcebergen's extensive experience and capabilities in pharmaceutical distribution have positioned the company as a key supplier for federal healthcare agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/13/23 |